The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE: Recent evidence indicates that carbon monoxide-releasing molecules (CO-RMs) exhibit potential anti-inflammatory properties. In the present study, we have investigated whether tricarbonyl dichloro ruthenium(II) dimer (CORM-2) can control the inflammatory response induced by cytokines in a human colonic epithelial cell line, Caco-2. EXPERIMENTAL APPROACH: Caco-2 cells were preincubated with CORM-2 for 30 minutes and then stimulated with interleukin (IL)-1beta, tumor necrosis factor-alpha and interferon-gamma for different times. Gene expression was analyzed by real-time PCR. Protein expression was investigated by Western blot and ELISA. Transcription factor activation was determined by the luciferase method. KEY RESULTS: We have shown that CORM-2 significantly decreased the mRNA expression of nitric oxide synthase-2 (NOS-2) and the production of nitrite, in Caco-2 cells stimulated with cytokines. IL-8, IL-6 and metalloproteinase-7 (MMP-7) mRNA and protein were also significantly reduced by CORM-2. Time-course and small interfering RNA studies suggest that inhibition of IL-6 plays a role in the regulation of MMP-7 expression by CORM-2. These effects of CORM-2 can be dependent on the modulation of nuclear factor-kappaB (NF-kappaB), activator protein-1, CCAT/enhancer binding protein and the phosphorylated forms of NF-kappaB inhibitory protein-alpha, c-Jun N-terminal protein kinase 1/2, p38 and extracellular signal-regulated kinase 1/2. CONCLUSIONS AND IMPLICATIONS: CORM-2 can regulate a number of genes relevant in intestinal inflammation and cancer progression. These findings provide new insights into the anti-inflammatory properties and potential applications of this class of compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations suggest that NF-κB is activated because of a lack of HO-1 derived anti-inflammatory molecules (CO, bilirubin) and is consistent with previous findings showing that the CO releasing compound, CORM-2, inhibits the DNA binding activity of NF-κB resulting in reduced TNFα production (Sawle et al., 2005; Megias et al., 2007; Motterlini et al., 2012).”
From Heme oxygenase 1 controls early innate immune response of macrophages to Salmonella Typhimurium infection: Heme oxygenase 1 expression affects Salmonella infection (2016) · cites this paper as Megias et al., 2007
Citations
Cites
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation
Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.009 · Cited by 1,496 · cited 1×
“Therefore, NF-kB is considered a therapeutic target for intestinal inflammatory diseases and cancer (Viatour et al., 2005).”
BackgroundHow NF-κB is activated: the role of the IκB kinase (IKK) complex
Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 1,156
A Fluorometric Assay for the Measurement of Nitrite in Biological Samples
Misko, T. P., Schilling, R. J., Salvemini, D., Moore, W. M., & Currie, M. G. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1449 · Cited by 1,027 · cited 2×
“levels In supernatants from 18 h cytomix-stimulated cells, NO2 was determined fluorometrically in microtiter plates using NaNO2 as a standard (Misko et al., 1993).”
MethodCarbon Monoxide-Releasing Molecules: Characterization of Biochemical and Vascular Activities
Motterlini, R., Clark, J. E., Foresti, R., Sarathchandra, P., Mann, B. E., & Green, C. J. (2002) · Circulation Research · doi:10.1161/hh0202.104530 · Cited by 998 · cited 2×
“The concentrations used are in the range of those previously reported in other cell lines (Motterlini et al., 2002) and Caco-2 cells (Busserolles et al., 2006).”
BackgroundWinzen, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.4969 · Cited by 777 · cited 2×
“On the other hand, p38 or ERK1/2 can play a role in the stabilization of IL-6 or IL-8 mRNA (Winzen et al., 1999; Choi et al., 2004).”
BackgroundJaiswal, M., LaRusso, N. F., Burgart, L. J., & Gores, G. J. (2000) · PubMed · Cited by 738
Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel, R., Baeuerle, P. A., Schölmerich, J., & Gross, V. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70202-1 · Cited by 715 · cited 2×
“Activation of NF-kB by cytokines correlates with the degree of mucosal inflammation in inflammatory bowel disease (Rogler et al., 1998) and plays a key role in NOS-2 and IL-8 induction (Nunokawa et al., 1996; Roebuck, 1999).”
BackgroundVanden Berghe, W., Plaisance, S., Boone, E., De Bosscher, K., Schmitz, M. L., Fiers, W., & Haegeman, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3285 · Cited by 679 · cited 1×
“Upon activation by stress and inflammatory cytokines, p38 translocates to the nucleus and regulates various transcription factors (Vanden Berghe et al., 1998).”
BackgroundCardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule
Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., Foresti, R., & Motterlini, R. (2003) · Circulation Research · doi:10.1161/01.res.0000084381.86567.08 · Cited by 673 · cited 2×
“, 2004) and cardioprotective (Clark et al., 2003) effects of this group of compounds.”
Background
Cited by
Niesel, J., Pinto, A., Peindy N'Dongo, H. W., Merz, K., Ott, I., Gust, R., & Schatzschneider, U. (2008) · Chemical Communications · doi:10.1039/b719075a · Cited by 267
Heme oxygenase-1 in tumor biology and therapy
Was, H., Dulak, J., & Jozkowicz, A. (2010) · Current Drug Targets · doi:10.2174/1389450111009011551 · Cited by 259
Use of carbon monoxide as a therapeutic agent: promises and challenges
Foresti, R., Bani-Hani, M. G., & Motterlini, R. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1011-1 · Cited by 251
NIR‐Responsive On‐Demand Release of CO from Metal Carbonyl‐Caged Graphene Oxide Nanomedicine
He, Q., Kiesewetter, D. O., Qu, Y., Fu, X., Fan, J., Huang, P., Liu, Y., Zhu, G., Liu, Y., Qian, Z., et al. (2015) · Advanced Materials · doi:10.1002/adma.201502762 · Cited by 211
Motterlini, R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351142 · Cited by 173
Kundu, J. K., & Surh, Y.-J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0096-8 · Cited by 173
“Furthermore, pretreatment with CORM-2 diminished mRNA expression of iNOS, IL-8, IL-6 and MMP-7, phosphorylation of mitogen-activated protein (MAP) kinases, and the reporter gene activity of NF-κB, AP-1 and CCAAT/ enhancer binding protein (C/EBP) in human colonic epithelial (Caco-2) cells stimulated with a mixture of T…”
BackgroundThe Diverse Roles of Heme Oxygenase-1 in Tumor Progression
Hoang, K. N. L., Anstee, J. E., & Arnold, J. N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658315 · Cited by 169
“NF-kB in particular, has been demonstrated to be vital for CD8+ T-cell effector function (123).”
BackgroundInfluentialHeme Oxygenase-1: Its Therapeutic Roles in Inflammatory Diseases
Pae, H., & Chung, H. (2009) · Immune Network · doi:10.4110/in.2009.9.1.12 · Cited by 167
Harnessing carbon monoxide-releasing platforms for cancer therapy
Zhou, Y., Yu, W., Cao, J., & Gao, H. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120193 · Cited by 149
Spontaneous CO Release from RuII(CO)2–Protein Complexes in Aqueous Solution, Cells, and Mice
Chaves‐Ferreira, M., Albuquerque, I. S., Matak‐Vinković, D., Coelho, A. C., Carvalho, S. M., Saraiva, L. M., Romão, C. C., & Bernardes, G. J. L. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201409344 · Cited by 144
Haem oxygenase-1: non-canonical roles in physiology and pathology
Grochot‐Przeczek, A., Dulak, J., & Józkowicz, A. (2011) · Clinical Science · doi:10.1042/cs20110147 · Cited by 155
De Backer, O., Elinck, E., Blanckaert, B., Leybaert, L., Motterlini, R., & Lefebvre, R. A. (2009) · Gut · doi:10.1136/gut.2008.155481 · Cited by 123
Hasan, R. N., & Schafer, A. I. (2007) · Circulation Research · doi:10.1161/circresaha.107.155143 · Cited by 131
Lin, C., Shen, S.-C., Hou, W., Yang, L., & Chen, Y. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2199 · Cited by 128
George, J. F., Braun, A. B., Brusko, T. M., Joseph, R., Bolisetty, S., Wasserfall, C. H., Atkinson, M. A., Agarwal, A., & Kapturczak, M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070963 · Cited by 131
Carbon Monoxide: An Essential Signalling Molecule
Mann, B. E. (2010) · Topics in organometallic chemistry · doi:10.1007/978-3-642-13185-1_10 · Cited by 124
Gaseous mediators in resolution of inflammation
Wallace, J. L., Ianaro, A., Flannigan, K. L., & Cirino, G. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.05.004 · Cited by 109
Wen, Z., Liu, H., Li, M., Li, B., Gao, W., Shao, Q., Fan, B., Zhao, F., Wang, Q., Xie, Q., et al. (2014) · Oncogene · doi:10.1038/onc.2014.85 · Cited by 109
Heme Catabolic Pathway in Inflammation and Immune Disorders
Wu, B., Wu, Y., & Tang, W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00825 · Cited by 97
Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs)
Motterlini, R., Haas, B., & Foresti, R. (2012) · Medical Gas Research · doi:10.1186/2045-9912-2-28 · Cited by 86
“This would not perhaps be surprising if we consider that CO-RMs seem to affect the activation of Nfkβ [24,25,52], which controls the expression iNOS and is a master regulator of major pathways in inflammation.”
BackgroundInfluentialKatada, K., Bihari, A., Mizuguchi, S., Yoshida, N., Yoshikawa, T., Fraser, D. D., Potter, R. F., & Cepinskas, G. (2009) · Inflammation · doi:10.1007/s10753-009-9162-y · Cited by 84
“With respect to the above, it has been shown that CO administered by inhalation does not change NF-κB activation [16, 54], however, treatment with CORM-2 [23, 24, 55] or CORM-3 [32] can effectively interfere with NF-κB activation.”
BackgroundVo, T. T. T., Vo, Q. C., Tuan, V. P., Wee, Y., Cheng, J. H.-C., & Lee, I. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102124 · Cited by 92
The Triple Crown: NO, CO, and H2S in cancer cell biology
Oza, P. P., & Kashfi, K. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108502 · Cited by 85
Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases
Naito, Y., Takagi, T., Uchiyama, K., & Yoshikawa, T. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.10-61 · Cited by 82
A Photoactive Carbon‐Monoxide‐Releasing Protein Cage for Dose‐Regulated Delivery in Living Cells
Fujita, K., Tanaka, Y., Abe, S., & Ueno, T. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201506738 · Cited by 80
Winburn, I. C., Gunatunga, K., McKernan, R., Walker, R. J., Sammut, I. A., & Harrison, J. C. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2012.00856.x · Cited by 86
Bauer, N., Yuan, Z., Yang, X., & Wang, B. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115642 · Cited by 79
Yoda, Y., Amagase, K., Kato, S., Tokioka, S., Murano, M., Kakimoto, K., Nishio, H., Umegaki, E., Takeuchi, K., & Higuchi, K. (2010) · PubMed · Cited by 75
The Carbon Monoxide Releasing Molecule CORM-2 Attenuates Pseudomonas aeruginosa Biofilm Formation
Murray, T. S., Okegbe, C., Gao, Y., Kazmierczak, B. I., Motterlini, R., Dietrich, L. E. P., & Bruscia, E. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035499 · Cited by 69
“Previous work has shown that CO-RM molecules are not toxic to mammalian cells [16,23] or when used intravenously in animal models [7].”
Anstee, J. E., Feehan, K. T., Opzoomer, J. W., Dean, I., Muller, H. P., Bahri, M., Cheung, T. S., Liakath‐Ali, K., Liu, Z., Choy, D., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2023.06.006 · Cited by 70
Muliaditan, T., Opzoomer, J. W., Caron, J., Okesola, M., Kosti, P., Lall, S. K., Hemelrijck, M. V., Dazzi, F., Tutt, A. N. J., Grigoriadis, A. E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2587 · Cited by 70
“Many of these effects have been attributed to CO due to its ability to modulate several signaling pathways including p38 MAPK (13), STAT1/3 (14), and NFkB (15, 16).”
BackgroundSoni, H., Pandya, G. M., Patel, P., Acharya, A., Jain, M. R., & Mehta, A. A. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.03.013 · Cited by 69
Carbon monoxide: An unusual drug
Gullotta, F., di Masi, A., & Ascenzi, P. (2012) · IUBMB Life · doi:10.1002/iub.1015 · Cited by 72
“CO-RMs have been shown to attenuate acute inflammatory response both in vitro and in vivo and to ameliorate neuroinflammatory response in microglia (71, 72).”
Mitterstiller, A.-M., Haschka, D., Dichtl, S., Nairz, M., Demetz, E., Talasz, H., Soares, M. P., Einwallner, E., Esterbauer, H., Fang, F. C., et al. (2016) · Cellular Microbiology · doi:10.1111/cmi.12578 · Cited by 62
“…is consistent with previous findings showing that the CO releasing compound, CORM-2, inhibits the DNA binding activity of NF-κB resulting in reduced TNFα © 2016 John Wiley & Sons Ltd, Cellular Microbiology, 18, 1374–1389 production (Sawle et al., 2005; Megias et al., 2007; Motterlini et al., 2012).”
Schallner, N., Romão, C. C., Biermann, J., Lagrèze, W. A., Otterbein, L. E., Buerkle, H., Loop, T., & Goebel, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060672 · Cited by 62
“For example, CORM-2 and CORM-3 exhibit anti-inflammatory effects through reduced NO2/nitriteproduction and iNOS expression [11,35,49].”
BackgroundGaseous Mediators in Gastrointestinal Mucosal Defense and Injury
Wallace, J. L., Ianaro, A., & Nucci, G. D. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4681-0 · Cited by 68
Chhikara, M., Wang, S., Kern, S. J., Ferreyra, G. A., Barb, J. J., Munson, P. J., & Danner, R. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008139 · Cited by 64
“CO inhibition of NF-kB activation has been associated with the suppression of a number of genes including GM-CSF [19], iNOS, ICAM-1[16], IL-8, IL-6 and MMP-7 [21].”
InfluentialNielsen, V. G., Kirklin, J. K., & George, J. F. (2009) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32832ca3a3 · Cited by 59
Onyiah, J. C., Sheikh, S. Z., Maharshak, N., Otterbein, L. E., & Plevy, S. E. (2014) · Gut Microbes · doi:10.4161/gmic.27290 · Cited by 56
Nrf2 is essential for the anti-inflammatory effect of carbon monoxide in LPS-induced inflammation
Qin, S., Du, R., Yin, S., Liu, X., Xu, G., & Cao, W. (2015) · Inflammation Research · doi:10.1007/s00011-015-0834-9 · Cited by 62
“One study showed that CO inhibited the expression of pro-inflammatory cytokines and iNOS by inhibiting NFjB/DNA binding as well as the I jB-a phosphorylation and degradation in Caco-2 cells [31].”
Zhang, A., Zhao, L., Li, N., Duan, H. Q., Liu, H., Pu, F., Zhang, G., Zhou, E., & Xiao, S. (2016) · Journal of Virology · doi:10.1128/jvi.01866-16 · Cited by 57
“reported that CORM-2 inhibits proinflammatory cytokines IL-6 and IL-8 after cytokine induction in Caco-2 cells (55).”
BackgroundPrevention of colitis by controlled oral drug delivery of carbon monoxide
Steiger, C., Uchiyama, K., Takagi, T., Mizushima, K., Higashimura, Y., Gutmann, M., Hermann, C., Botov, S., Schmalz, H., Naito, Y., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.030 · Cited by 61
Guillén, M. I., Megías, J., Clérigues, V., Gomar, F., & Alcaraz, M. J. (2008) · Rheumatology · doi:10.1093/rheumatology/ken264 · Cited by 54
Self-citationCO and CO ‐releasing molecules ( CO ‐ RMs ) in acute gastrointestinal inflammation
Babu, D., Motterlini, R., & Lefebvre, R. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12632 · Cited by 57
“Consistently, CO treatment reduced the cytokine-induced expression of iNOS at the mRNA or protein level, correlating with suppression of nitrite production (Dijkstra et al., 2004; Zuckerbraun et al., 2005b; Megias et al., 2007).”
BackgroundInfluentialde Oliveira, M. R., Ferreira, G. C., Brasil, F. B., & Peres, A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0380-7 · Cited by 50
Magierowska, K., Magierowski, M., Hubalewska‐Mazgaj, M., Adamski, J., Surmiak, M., Śliwowski, Z., Kwiecień, S., & Brzozowski, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140493 · Cited by 53
“In cytokine-stimulated Caco-2 cells CORM-2 regulates metalloproteinase-7 expression by inhibiting the IL-6 gene and downregulation of IL-8 which could be responsible for a partial resolution of ulcerative colitis and Crohn's disease in vivo [37].”
BackgroundDatta, P., Mukhopadhyay, A. P., Manna, P., Tiekink, E. R. T., Sil, P. C., & Sinha, C. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.04.013 · Cited by 52
Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole
Higuchi, K., Yoda, Y., Amagase, K., Kato, S., Tokioka, S., Murano, M., Takeuchi, K., & Umegaki, E. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.sr09-58 · Cited by 51
“Another report indicated that CO has an anti-inflammatory effect by inhibiting NFκB activity [49, 50].”
Current trends in gas-synergized phototherapy for improved antitumor theranostics
Yan, Z., Liu, Z., Zhang, H., Guan, X., Xu, H., Zhang, J., Zhao, Q., & Wang, S. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.12.012 · Cited by 47
Vareille, M., Rannou, F., Thélier, N., Glasser, A.-L., de Sablet, T., Martin, C., & Gobert, A. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5720 · Cited by 45
“Therefore, we propose that CO is the key element of iNOS gene regulation, as recently established in Caco-2 cells (35).”
BackgroundCosta, D. L., Amaral, E. P., Andrade, B. B., & Sher, A. (2020) · Antioxidants · doi:10.3390/antiox9121205 · Cited by 47
Zimmermann, A., Leffler, C. W., Tcheranova, D., Fedinec, A. L., & Parfenova, H. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00354.2007 · Cited by 45
Metal-based carbon monoxide releasing molecules with promising cytotoxic properties
Mansour, A. M., Khaled, R. M., Ferraro, G., Shehab, O. R., & Merlino, A. (2024) · Dalton Transactions · doi:10.1039/d4dt00087k · Cited by 46
Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma
Nielsen, V. G., Kirklin, J. K., & George, J. F. (2009) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32832f4335 · Cited by 44
Peptide Anchor for Folate-Targeted Liposomal Delivery
Nogueira, E., Mangialavori, I. C., Loureiro, A., Azóia, N. G., Sárria, M. P., Nogueira, P., Freitas, J., Härmark, J., Shimanovich, U., Rollett, A., et al. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00823 · Cited by 41
Localized delivery of carbon monoxide
Steiger, C., Hermann, C., & Meinel, L. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.11.002 · Cited by 44
A New Role for Myeloid HO-1 in the Innate to Adaptive Crosstalk and Immune Homeostasis
Koliaraki, V., & Kollias, G. A. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5632-3_9 · Cited by 41
“More specifically, HO-1 appears to act through the p38 MAPK pathway, the NFkB pathway or the induction of cGMP in order to inhibit the LPS-induced production of iNOS, COX2 and pro-inflammatory cytokines, such as TNF, IL1b, and MIP-1a in macrophages [41, 59, 74] and epithelial cells [ 38 ].”
BackgroundWang, X., Qin, W., Song, M., Zhang, Y., & Sun, B. (2016) · Oncotarget · doi:10.18632/oncotarget.9084 · Cited by 37
Mansour, A. M., Khaled, R. M., Tharwat, E. K., Ahmed, S. K., Ismael, O. S., Zeinhom, A., Magdy, H., Ibrahim, S. S., & Abdelfatah, M. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114991 · Cited by 37
Ultraviolet-A1 irradiation therapy for systemic lupus erythematosus
McGrath, H. (2017) · Lupus · doi:10.1177/0961203317707064 · Cited by 36
Fukuda, W., Takagi, T., Katada, K., Mizushima, K., Okayama, T., Yoshida, N., Kamada, K., Uchiyama, K., Ishikawa, T., Handa, O., et al. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-3014-1 · Cited by 34
Extracellular matrix proteases - cytokine regulation role in cancer and pregnancy
Huang, S., Sheu, B.-C., Chang, W.-C., Cheng, C.-Y., Wang, P.-H., & Lin, S. (2009) · Frontiers in bioscience · doi:10.2741/3325 · Cited by 34
“Recently, screening systems of utility for small compounds that disrupt the interaction network of suppressed MMP expression have been developed (100-105).”
BackgroundSpontaneous CO Release from RuII(CO)2–Protein Complexes in Aqueous Solution, Cells, and Mice
Chaves‐Ferreira, M., Albuquerque, I. S., Matak‐Vinković, D., Coelho, A. C., Carvalho, S. M., Saraiva, L. M., Romão, C. C., & Bernardes, G. J. L. (2014) · Angewandte Chemie · doi:10.1002/ange.201409344 · Cited by 32
Nguyen, D., Adnan, N. N. M., Oliver, S., & Boyer, C. A. (2016) · Macromolecular Rapid Communications · doi:10.1002/marc.201500755 · Cited by 31
Carbon monoxide releasing molecule-2 ameliorates IL-1β-induced IL-8 in human gastric cancer cells
Lian, S., Xia, Y., Ung, T. T., Khoi, P. N., Yoon, H. J., Kim, N. H., Kim, K. K., & Jung, Y. D. (2016) · Toxicology · doi:10.1016/j.tox.2016.07.003 · Cited by 33
“…of NADPH oxidase (Taillé et al. 2005). iii) CO attenuates the inflammatory response elicited by lipopolysaccharide (Sawle et al. 2005) or cytokines (Megias et al. 2007). iv) CO inhibits various genes, including eukaryotic elongation factor-2 (Schwer et al. 2013), intracellular adhesion molecule-1…”
BackgroundHsu, C., Vo, T. T. T., Lee, C., Chen, Y., Lin, W., Cheng, J. H.-C., Vo, Q. C., & Lee, I. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114978 · Cited by 30
Friend or foe? Carbon monoxide and the mitochondria
Schallner, N., & Otterbein, L. E. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00017 · Cited by 30
“…and have been characterized to deliver CO to target tissues in several in vitro(Clark et al., 2003; Motterlini et al., 2005; Bani-Hani et al., 2006; Megias et al., 2007; Urquhart et al., 2007) and in vivo (Tayem et al., 2006; De Backer et al., 2009; Tsoyi et al., 2009; Vadori et al., 2009)…”
BackgroundGao, C., Liang, X., Guo, Z., Jiang, B., Liu, X., & Shen, X. (2018) · ACS Omega · doi:10.1021/acsomega.8b00052 · Cited by 28
Babu, D., Soenen, S. J., Raemdonck, K., Leclercq, G., Backer, O. D., Motterlini, R., & Lefebvre, R. A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802481291 · Cited by 29
“[23] Megías J, Busserolles J, Alcaraz MJ.”
BackgroundNielsen, V. G., Kirklin, J. K., George, J. F., & Messinger, J. D. (2009) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3283333c5d · Cited by 26
Schwer, C. I., Stoll, P., Rospert, S., Fitzke, E., Schallner, N., Bürkle, H., Schmidt, R., & Humar, M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.09.020 · Cited by 26
Rufino, A. T., Ferreira, I., Judas, F., Salgueiro, L., Lopes, M. C., Cavaleiro, C., & Mendes, A. F. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2014.970701 · Cited by 24
Megías, J., Guillén, M. I., Bru, A., Gomar, F., & Alcaraz, M. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134650 · Cited by 24
“56 derived from heme oxygenase-1 (HO-1) activity (for review, see Foresti et al., 2005).”
BackgroundSelf-citationLv, C., Su, Q., Fang, J. Q., & Yin, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.112 · Cited by 22
El‐Achkar, G. A., Mrad, M. F., Mouawad, C. A., Badran, B. M., Jaffa, A. A., Motterlini, R., Hamade, E., & Habib, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216405 · Cited by 20
Chi, P., Chuang, Y., Chen, Y., Lin, C., Hsiao, L., & Yang, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12680 · Cited by 19
“Similarly, inhibition of NF-κB activation by CORM-2 was dependent on the inhibition of p65 phosphorylation in cytokine-stimulated Caco-2 cells (Megias et al., 2007).”
MethodMetal Carbonyl Prodrugs: CO Delivery and Beyond
Romão, C. C., & Vieira, H. L. A. (2014) · Wiley eBooks · doi:10.1002/9783527673438.ch06 · Cited by 19
A Central Role for Heme Oxygenase-1 in the Control of Intestinal Epithelial Chemokine Expression
Onyiah, J. C., Schaefer, R. E. M., & Colgan, S. P. (2018) · Journal of Innate Immunity · doi:10.1159/000488914 · Cited by 17
Takagi, T., Naito, Y., Uchiyama, K., Okuda, T., Suzuki, T., Tsuboi, H., Mizushima, K., Handa, O., Yagi, N., Ichikawa, H., et al. (2012) · Medical Gas Research · doi:10.1186/2045-9912-2-23 · Cited by 17
“also described that CO inhibited IL-8 production in a human colonic epithelial cell line, Caco-2, through the inhibition of NF-κB activation [27].”
BackgroundMu, X., Pan, C., Zheng, S., Alhamdi, Y., Sun, B., Shi, Q., Wang, X., Sun, Z., Toh, C., & Wang, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104032 · Cited by 17
“Moreover, other researchers reported that CORM-2 could suppress the inflammatory response induced by cytokines in Caco-2 cells, a human intestinal carcinoma cell line [15].”
BackgroundInaba, H., Sanghamitra, N. J. M., Fujita, K., Sho, T., Kuchimaru, T., Kitagawa, S., Kizaka‐Kondoh, S., & Ueno, T. (2015) · Molecular BioSystems · doi:10.1039/c5mb00327j · Cited by 17
Carbon monoxide-releasing molecule attenuates allograft airway rejection
Ohtsuka, T., Kaseda, K., Shigenobu, T., Hato, T., Kamiyama, I., Goto, T., Kohno, M., & Shimoda, M. (2014) · Transplant International · doi:10.1111/tri.12314 · Cited by 15
Nielsen, V. G., Kirklin, J. K., & George, J. F. (2009) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e328331fd00 · Cited by 15
Chemistry and biology of manganese carbon-releasing molecules containing thiosemicarbazone ligands
Daniels, H. G., Fast, O. G., Shell, S. M., & Beckford, F. A. (2019) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2019.01.037 · Cited by 14
Duarte, A. R., Chenet, A. L., de Almeida, F. J. S., Andrade, C. M. B., & de Oliveira, M. R. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.09.012 · Cited by 14
Silva, R. O., Soares, P. M. G., Barbosa, A. L. D. R., Nicolau, L. A. D., Medeiros, J. V. R., & de Souza, M. H. L. P. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8223 · Cited by 14
Hovater, M. B., Ying, W., Agarwal, A., & Sanders, P. W. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00353.2014 · Cited by 12
“The doses used in these experiments were typical of the concentrations of NOR3 used by many other laboratories to demonstrate a biological effect (5, 11, 20, 30, 32, 36, 45, 46, 52, 62) and generally less than that used to show a biological effect for CORM2 (5, 11, 20, 30, 32, 36, 45, 46, 52, 62).”
MethodPhysiological activities of carbon monoxide‐releasing molecules: Ça ira
Chatterjee, P. K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707185 · Cited by 11
Tamasi, G., & Cini, R. (2013) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2013.05.030 · Cited by 10
Davies, A. L., Kramer, J. L. K., & Hayes, K. C. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.12.002 · Cited by 10
CORM-2 Pretreatment Attenuates Inflammation-mediated Islet Dysfunction
Cai, X., Wang, G., Liang, R., Wang, L., Liu, T.-L., Zou, J., Liu, N., Liu, Y., Wang, S., & Shen, Z. (2020) · Cell Transplantation · doi:10.1177/0963689720903691 · Cited by 9
Oral Use of Therapeutic Carbon Monoxide for Anyone, Anywhere, and Anytime
Reiländer, S., Schmehl, W., Popp, K., Nuss, K. M. R., Kronen, P., Verdino, D., Wiezorek, C., Gutmann, M., Hahn, L., Däubler, C., et al. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00464 · Cited by 10
Nielsen, V. G., Malayaman, S. N., Cohen, J. B., & Persaud, J. M. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.09.007 · Cited by 8
“We chose this concentration originally [10, 11] as it was in the low tomidrange of reported CORM-2 concentrations associated with vasodilation and improved outcomes in cell culture without discernable toxicity [22, 23].”
A Photoactive Carbon‐Monoxide‐Releasing Protein Cage for Dose‐Regulated Delivery in Living Cells
Fujita, K., Tanaka, Y., Abe, S., & Ueno, T. (2015) · Angewandte Chemie · doi:10.1002/ange.201506738 · Cited by 7
Chigaev, A., Smagley, Y., & Sklar, L. A. (2014) · BMC Immunology · doi:10.1186/s12865-014-0052-1 · Cited by 7
“RuCl3 is a product of CORM-2 degradation, and therefore, it was used as a negative control in CORM-2 experiments [44-47].”
MethodSzabó, C. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc178 · Cited by 11
From canes to pills: the evolution of carbon monoxide therapeutics
Halbig, F., Reiländer, S., Keßler, C., Ort, D., Schmehl, W., Kehrein, J., Gutmann, M., Däubler, C., Michel, M., Witte, R., et al. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115858 · Cited by 6
Therapeutic Gases in Biomedicine: Updates on Nitric Oxide and Beyond
Andrabi, S. M., Sharma, N. S., Rather, I., Shahriar, S. M. S., & Xie, J. (2026) · Advanced Science · doi:10.1002/advs.202521942 · Cited by 5
Meng, X., Fei, D., Liu, M., Yang, S., Ning, S., Jiang, L., Kang, K., Nan, C., Luo, Y., Pan, S., et al. (2017) · Medicine · doi:10.1097/md.0000000000006978 · Cited by 4
Metal‐Based Carbon Monoxide‐Releasing Molecules (CO‐RMs) as Pharmacologically Active Therapeutics
Foresti, R., Benrahla, D. E., Mohan, S., & Motterlini, R. (2022) · Wiley eBooks · doi:10.1002/9781119783435.ch12 · Cited by 3
Metadata
- Authors
- Megías, J., Busserolles, J., & Alcaraz, M. J.
- Affiliations
- Universitat de València (ES)
- Corresponding author
- Alcaraz, M J
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-04
- Volume
- 150
- Issue
- 8
- Pages
- 977-986
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC2013913
- OpenAlex
- W1484225253
- Cited by
- 117
- References
- 70
- Citations by year
- 2026: 3 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 7 · 2015: 11 · 2014: 12 · 2013: 6 · 2012: 7
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Generalitat Valenciana
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- CORM-2, carbon monoxide-releasing molecules, anti-inflammatory activity, intestinal inflammation, Caco-2 cells, cytokine-induced inflammation, IL-1β, TNF-α, interferon-gamma, nitric oxide synthase 2, nitrite production, interleukin-6, MMP-7, NF-κB, AP-1, CREB, MAPK signaling, c-Jun N-terminal kinase, p38 MAPK, ERK1/2, colonic epithelium
- MeSH terms
- NF-KappaB Inhibitor alpha, Anti-Inflammatory Agents, Carbon Monoxide, Dose-Response Relationship, Drug, Epithelial Cells, Humans, Inflammation, Interferon-gamma, Intestinal Mucosa, Organometallic Compounds, Phosphorylation, RNA, Messenger, Time Factors, Tumor Necrosis Factor-alpha, Interleukin-6, Gene Expression, Cytokines, Interleukin-8, NF-kappa B, Transcription Factor AP-1, Caco-2 Cells, I-kappa B Proteins, Matrix Metalloproteinase 7, MAP Kinase Signaling System, CCAAT-Enhancer-Binding Proteins, Nitric Oxide Synthase Type II, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.